Recalls / Class II
Class IID-0855-2017
Product
SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-044-01
- Affected lot / code info
- Lot #: WXWZ, Exp. March 2019; WXTS, Exp. October 2019
Why it was recalled
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Recalling firm
- Firm
- Sato Pharmaceutical Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 20695 S Western Ave Ste 240, Torrance, California 90501-1834
Distribution
- Quantity
- 4,790 bottles
- Distribution pattern
- US: Hawaii, Guam, Saipan, SPI
Timeline
- Recall initiated
- 2017-02-16
- FDA classified
- 2017-05-23
- Posted by FDA
- 2017-05-31
- Terminated
- 2018-03-13
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0855-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.